Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
39% <60% <5%
General Information
Version
3.1, 29.11.2016
Revision date
2016-11-29
Product name
EMPLICITI (elotuzumab) for injection
Product Synonyms
Empliciti (elotuzumab)300 mg/vial and 400 mg/vial, Elotuzumab Lyophilized powder for Injection, 300 mg/vial and 400 mg/vial; BMS-901608-01; HuLuc63
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used in the treatment of cancer. It is a protein
Icons in SDS
Company Information
company name
USA
e-mail address of the competent person responsible for the Safety Data Sheet
MG-GBS-MSDS-Request@bms.com
Section 2
SECTION 2: Hazards identification
Classification and Labelling Common to All Jurisdictions
2.1 Classification of the substance or mixture
Not Rated Substance not fully tested.
Precautionary statements
Wash hands after handling to minimize exposure. Handle as a potentially hazardous material. Avoid ingestion, inhalation, skin and eye contact.
Further information
99.7% of the mixture consists of ingredients(s) of unknown hazards to the aquatic environment.
